Cellumen
Pittsburgh
About Cellumen
Cellumen is the innovator in cellular systems biology (CSB™) solutions providing the most accurate predictions of drug efficacy and safety, thus reducing failure rates and cutting development costs. Cellumen’s CSB solutions are driving Discovery Toxicology by addressing the full complexity of disease and safety. Leading global organizations, such as the Mayo Clinic, Hamamatsu Photonics K.K., the EPA, FDA, NIH and top pharmaceutical companies, partner with Cellumen. Cellumen is a partner company of Safeguard Scientifics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.6M
- Funding stage: M&A
- Last round: Series Unknown (Mar 2010)
- Website: cellumen.com
- Phone: +1 412-481-5690
Industries & Categories
Biofuel, Biotechnology, Life Science
Canonical: https://fsome.com/organization/cellumen-2982532 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.